XBiotech Inc.
Company Stats
- Market Cap
- $66.8M
- as of Sep 30, 2026
- Shares Outstanding
- 30.5M
- Free Float
- 67.4%
Income Statement
- Operating Income
- -$55.7M
- Net Income
- -$45.5M
- EBITDA
- -$54.0M
Cash Flow
- Free Cash Flow
- -$40.2M
- FCF Yield
- -60.2%
- Owner FCF Yield
- -65.6%
Balance Sheet
- Cash & Equivalents
- $125.6M
Returns & Capital
- SBC, 3Y Avg
- $2.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$40.2M | — |
| FY2024 | — | -$32.3M | — |
| FY2023 | $0 | -$19.1M | — |
| FY2022 | $4.0M | -$15.4M | -384.3% |
| FY2021 | $18.4M | $65.9M | 358.4% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
XBiotech Leads Buying Intensity; Gold.com Draws $3.93 Million